NEW BRUNSWICK, N.J., Feb. 8, 2018 /PRNewswire/ — Janssen Research & Development, LLC (Janssen) and Johnson & Johnson (NYSE: JNJ) will provide a pre-recorded webcast focusing on the Phase 3 SPARTAN data for the investigational compound apalutamide in non-metastatic…
